223671-94-1Relevant articles and documents
(7-(3-Carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
-
, (2008/06/13)
The invention described herein relates to a process for the preparation of (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine (I), intermediates thereto and new forms and formulations thereof, including the zwitterion monohydrate of (I), suitable for
Isoquinolines as urokinase inhibitors
-
, (2008/06/13)
Compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors.